Nephron Pharma Recalls 2+ Million Products

The South Carolina based company recently invested $215.8 million in the facility that produces generic inhalation and suspension products.

Screen Shot 2022 04 18 At 2 42 14 Pm
Getty Images

A recent WIS News article discussed a massive recall from Nephron Sterile Compounding Center. Somewhat ironically, 2.1 million doses of medicine and medical equipment were recalled due to “lack of assurance of sterility.” The recall began on May 18th, and includes a total of 2,158,351 pieces of medicine and equipment including syringes and bags.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO